Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85